Blog
RSS FeedPosted by Michael Wonder on 01 Sep 2018
Schedule of Pharmaceutical Benefits - 1 September 2018 update
1 September 2018 - The September 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Aug 2018
Pharma interactions educate and improve health outcomes
31 August 2018 - Medicines Australia is pleased to announce the release of the fifth biannual innovative medicines industry’s transfer ...
Posted by Michael Wonder on 31 Aug 2018
Medicines Australia welcomes announcement LSDP Expert Panel
31 August 2018 - Medicines Australia welcomes today’s announcement by Minister for Health, the Hon Greg Hunt MP on the ...
Posted by Michael Wonder on 31 Aug 2018
New Zealand Pharmaceutical Schedule - 1 September 2018 update
1 September 2018 - The September 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Aug 2018
Expensive life-prolonging drug not an option for many women
30 August 2018 - Wiki Mulholland has the toughest of balancing acts – between staying alive and draining her family ...
Posted by Michael Wonder on 30 Aug 2018
Woman's desperate plea to PHARMAC to fund $6,000/month cancer drug
31 august 2018 - A New Zealand woman is pleading with pharmaceutical giant PHARMAC and MPs to fund an expensive ...
Posted by Michael Wonder on 30 Aug 2018
Renflexis (infliximab for injection) added to British Columbia's Provincial Drug Plan for all approved indications
22 August 2018 - Renflexis has been added to drug formulary for the treatment of adult and paediatric Crohn's disease and ...
Posted by Michael Wonder on 30 Aug 2018
So the Government has agreed to reduce the time from PBAC recommendation to PBS listing by two months
30 August 2018 - How will this new objective be assessed? ...
Posted by Michael Wonder on 30 Aug 2018
Proposal to list sapropterin for use in pregnancy by women with phenylketonuria
30 August 2018 - PHARMAC is seeking feedback on a proposal to fund sapropterin tablets, a treatment for the rare ...
Posted by Michael Wonder on 29 Aug 2018
Cancer charities dismayed after ‘new generation’ therapy rejected as too expensive
29 August 2018 - A NICE committee said the cost of the drug was “too high for it to be considered ...
Posted by Michael Wonder on 29 Aug 2018
Patients being bled by specialists as out-of-pocket costs surge
30 August 2018 - Health insurance giant Medibank has warned that one in eight of its customers is being forced ...
Posted by Michael Wonder on 29 Aug 2018
Life-changing drug Spinraza for spinal muscular atrophy patients costing adults at least $500,000
29 August 2018 - In a small lounge in Essendon, with his parents by his side, Chris Kessaris sat in ...
Posted by Michael Wonder on 29 Aug 2018
B.C. to sue opioid makers for health care expenses of overdose crisis
29 August 2018 - The British Columbia Government will sue opioid manufacturers including Purdue Pharma in an effort to recoup ...
Posted by Michael Wonder on 29 Aug 2018
Developing tools to support digital health and medtech innovation
8 August 2018 - NICE is involved in two key initiatives with national partners to achieve these aims by developing standards ...
Posted by Michael Wonder on 29 Aug 2018
Proposal to move to one funded brand of lamotrigine (Logem)
29 August 2018 - PHARMAC is seeking feedback on a proposed change to the funding of lamotrigine dispersible tablets used ...